National Guideline Clearinghouse | Guidelines by Topic: Macular Degeneration

National Guideline Clearinghouse | Guidelines by Topic: Macular Degeneration

Guidelines by Topic

Disease/Condition > Diseases (1972) > Eye Diseases (61) > Retinal Diseases (25) > Retinal Degeneration (10) >

Macular Degeneration (10)

Narrow:

Macular Edema (7)
Wet Macular Degeneration (1)

1-10 of 10
1.   Food and nutrition for older adults promoting health and wellness (FNOA). 2012. NGC:009563 Academy of Nutrition and Dietetics - Professional Association. View all guidelines by the developer(s) Compare Selected
2.   Aflibercept solution for injection for treating wet age-related macular degeneration. 2013 Jul. NGC:009971 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
3.   Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion. 2013 May. NGC:009895 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
4.   Occupational therapy practice guidelines for older adults with low vision. 2013. NGC:010073 American Occupational Therapy Association, Inc. - Professional Association. View all guidelines by the developer(s) Compare Selected
5.   Dexamethasone intravitreal implant for treating diabetic macular oedema. 2015 Jul 22. NGC:010778 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
6.   Aflibercept for treating diabetic macular oedema. 2015 Jul. NGC:010771 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
7.   Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion. 2014 Feb. NGC:010285 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
8.   Evidence-based clinical practice guideline: eye care of the patient with diabetes mellitus. 1993 (revised 2014). NGC:010318 American Optometric Association - Professional Association. View all guidelines by the developer(s) Compare Selected
9.   Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237).2013 Apr. NGC:009630 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
10.   Fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular oedema after an inadequate response to prior therapy. 2013 Jan. NGC:009631 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
1-10 of 10